Prevalence of hearing loss, tinnitus, vertigo and sudden deafness among patients with polymyositis and dermatomyositis

Shih-Han Hung,Sudha Xirasagar,Luong Huu Dang,Nguyen-Kieu Viet-Nhi,Yen-Fu Cheng,Chin-Shyan Chen,Herng-Ching Lin
DOI: https://doi.org/10.1038/s41598-024-56372-z
IF: 4.6
2024-03-11
Scientific Reports
Abstract:Little is known about a possible association of autoimmune inner ear disease among patients diagnosed with polymyositis (PM)/dermatomyositis (DM). This study aimed to explore differences in the prevalence of inner ear symptoms among patients with and without PM/DM using a nationwide population-based dataset. Data for this study were retrieved from the Taiwan National Health Insurance Research Database. The study sample included 1622 patients diagnosed with PM/DM and 8109 propensity-score matched comparison patients without PM/DM. We performed multivariate logistic regressions to calculate odds ratios (ORs) and 95% confidence interval (CI) for tinnitus, hearing loss, sudden deafness, and vertigo among patients with PM/DM versus comparison patients. Chi-square tests showed statistically significant differences between patients with PM/DM and comparison patients in the prevalence of tinnitus (16.1% vs. 12.7%, p < 0.001), non-conductive hearing loss (9.2% vs. 6.8%, p < 0.001), and vertigo (14.4% vs. 11.1%, p < 0.001). The adjusted ORs for tinnitus, non-conductive hearing loss, and vertigo, respectively, were 1.332 (95% CI = 1.147–1.547), 1.399 (95% CI = 1.154–1.696), and 1.374 (95% CI = 1.173–1.611) for patients with PM/DM when compared to comparison patients. Our study finds that patients with PM/DM have higher prevalence rates of tinnitus, non-conductive hearing loss, and vertigo than comparison patients.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem this paper attempts to address is whether the prevalence of inner ear symptoms (such as tinnitus, hearing loss, sudden deafness, and vertigo) is higher in patients with polymyositis (PM) and dermatomyositis (DM) compared to non-PM/DM patients. Specifically, the study aims to compare the differences in inner ear symptoms between PM/DM patients and non-PM/DM patients using a nationwide population dataset to understand if these two autoimmune diseases are associated with inner ear diseases. ### Research Background - **Autoimmune Inner Ear Disease (AIED)**: Although AIED is relatively rare, its diagnosis is often overlooked due to the lack of specific diagnostic tests. AIED can lead to symptoms such as tinnitus, hearing loss, and vertigo. - **Polymyositis (PM) and Dermatomyositis (DM)**: These two diseases are rare autoimmune inflammatory myopathies often accompanied by various systemic complications, including interstitial lung disease and cardiovascular diseases. Currently, little is known about the association between PM/DM and AIED. ### Research Objectives - **Explore the prevalence differences in inner ear symptoms between PM/DM patients and non-PM/DM patients**: By analyzing data from the Taiwan National Health Insurance Research Database, the study compares the prevalence of tinnitus, non-conductive hearing loss, sudden deafness, and vertigo between the two groups of patients. - **Evaluate the potential association between PM/DM and inner ear diseases**: Using multivariable logistic regression analysis, the study calculates the adjusted odds ratios (OR) and 95% confidence intervals (CI) to determine the differences in inner ear symptoms between PM/DM patients and non-PM/DM patients. ### Research Methods - **Data Source**: Taiwan National Health Insurance Research Database (LHID2010). - **Sample Selection**: 1622 PM/DM patients and 8109 matched non-PM/DM patients. - **Statistical Analysis**: Chi-square tests and t-tests were used to compare the demographic characteristics and prevalence of inner ear symptoms between the two groups of patients; multivariable logistic regression analysis was used to calculate the adjusted OR and 95% CI. ### Main Findings - **Tinnitus**: The prevalence in PM/DM patients was 16.1%, compared to 12.7% in non-PM/DM patients (p < 0.001). - **Non-conductive Hearing Loss**: The prevalence in PM/DM patients was 9.2%, compared to 6.8% in non-PM/DM patients (p < 0.001). - **Vertigo**: The prevalence in PM/DM patients was 14.4%, compared to 11.1% in non-PM/DM patients (p < 0.001). - **Sudden Deafness**: There was no significant difference in the prevalence of sudden deafness between the two groups (1.0% vs. 1.1%, p = 0.662). ### Conclusion - **PM/DM patients are more likely to experience tinnitus, non-conductive hearing loss, and vertigo compared to non-PM/DM patients**. This finding may help in the early diagnosis and prevention of otolaryngological complications in PM/DM patients. - **Further Research**: More studies are needed to validate these findings and explore the causal mechanisms leading to these associations.